Samidorphan is a novel opioid system modulator, mainly acting as a μ-opioid receptor antagonist, with additional partial agonist activity at κ- and δ-opioid receptors. It is structurally related to naltrexone but has greater oral bioavailability and a longer elimination half-life (7–9 hours). Its therapeutic use is listed as alcohol dependence agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include samidorphanum and samidorfano. Its PubChem CID is 11667832.
Samidorphan
| CAS No | 852626-89-2 |
|---|---|
| Molecular Formula | C21H26N2O4 |
| Molecular Weight | 370.4 g/mol |
| Synonyms | (1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Samidorphan is a novel opioid system modulator, mainly acting as a μ-opioid receptor antagonist, with additional partial agonist activity at κ- and δ-opioid receptors.
The listed CAS number is 852626-89-2.
The listed molecular formula is C21H26N2O4.
The listed molecular weight is 370.4 g/mol.
(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide.
The source lists samidorphanum and samidorfano.